Plasma protein kallikrein-14 strongly predicts pronounced chromogranin. A response in small intstinal neuroendocrine tumour patients after somatostatin analogue treatment: the Nordic EXPLAIN biomarker study. The Nordic NET Biomarker Group

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdatomar. 2018
StatusUdgivet - mar. 2018
BegivenhedENETS - Barcelona, Spanien
Varighed: 15. mar. 2018 → …

Konference

KonferenceENETS
LandSpanien
ByBarcelona
Periode15/03/2018 → …

Citer dette

@conference{f2c9b5ac6b984ca9a6ca452548766950,
title = "Plasma protein kallikrein-14 strongly predicts pronounced chromogranin. A response in small intstinal neuroendocrine tumour patients after somatostatin analogue treatment: the Nordic EXPLAIN biomarker study. The Nordic NET Biomarker Group",
author = "J{\o}rgensen, {Maiken Thyregod}",
year = "2018",
month = "3",
language = "English",
note = "null ; Conference date: 15-03-2018",

}

TY - ABST

T1 - Plasma protein kallikrein-14 strongly predicts pronounced chromogranin. A response in small intstinal neuroendocrine tumour patients after somatostatin analogue treatment: the Nordic EXPLAIN biomarker study. The Nordic NET Biomarker Group

AU - Jørgensen, Maiken Thyregod

PY - 2018/3

Y1 - 2018/3

M3 - Conference abstract for conference

ER -